Insider Sale: Director at $CDNA Sells 19,391 Shares

Director WILLIAM A HAGSTROM sold 19,391 shares of $CDNA on 06-11-2025 for approximately $385,917, representing 26.4% of his holdings. Over the past six months, $CDNA insiders have executed 10 sales and 0 purchases. In Q1 2025, institutional investors showed mixed sentiment with 104 increasing and 140 decreasing their positions, with notable increases from OPHIR ASSET MANAGEMENT PTY LTD and HOOD RIVER CAPITAL MANAGEMENT LLC, and decreases from MILLENNIUM MANAGEMENT LLC and BELLEVUE GROUP AG.

Analysis

CareDx, Inc. ($CDNA) has experienced significant insider selling activity, highlighted by director William A. Hagstrom's sale of 19,391 shares on June 11, 2025, for an estimated $385,917, which constituted approximately 26.4% of his holdings in that class of stock. This individual transaction is part of a broader trend within the company, as $CDNA insiders have exclusively engaged in sales over the past six months, totaling 10 distinct sale transactions and zero purchases. Notable among these are Hagstrom's cumulative sales of 49,391 shares for an estimated $909,330, Christine Cournoyer's sales of 45,836 shares for an estimated $700,951, and sales by other key personnel including George Bickerstaff, Peter Maag, Jeffrey Adam Novack (Secretary and General Counsel), and Abhishek Jain (Chief Financial Officer). This consistent selling pressure from multiple insiders, coupled with a reported moderately negative sentiment score of -0.6 for $CDNA, raises concerns. Concurrently, institutional investor sentiment in Q1 2025 presented a mixed picture: while 104 institutional investors added $CDNA shares, a larger cohort of 140 decreased their positions. Significant new or increased stakes were reported by OPHIR ASSET MANAGEMENT PTY LTD (adding 1,618,369 shares for an estimated $28.7 million) and HOOD RIVER CAPITAL MANAGEMENT LLC (adding 1,583,956 shares for an estimated $28.1 million). Conversely, prominent divestitures included MILLENNIUM MANAGEMENT LLC reducing its stake by 518,698 shares (-83.5%) and POINT72 ASSET MANAGEMENT, L.P. exiting its position entirely by selling 465,665 shares.

Key Decisions for Investors

• Investors should exercise caution regarding $CDNA due to the consistent and widespread insider selling observed over the past six months, which may signal a lack of confidence from those with intimate knowledge of the company.
• Closely monitor upcoming institutional holding disclosures and any shifts in insider transaction patterns, as continued net selling by institutions alongside persistent insider sales could further pressure the stock.
• Consider the divergence in institutional activity, where some large funds are accumulating shares while others are significantly reducing or exiting positions, suggesting a need for deeper due diligence into the specific theses driving these large trades before making investment decisions.